Today Frank Yiannas informed Commissioner Robert Califf of the U. S. Food and Drug Administration that he will be resigning his position as Deputy Commissioner for the Office of Food Policy and Response at the
Continue Reading Frank Yiannas, Deputy Commissioner of Food Policy and Response, submits his resignation
Abbott Laboratories’ infant-formula plant in Sturgis, MI, is the apparent target of a federal criminal investigation by the U.S. Department of Justice’s Consumer Protection Branch.
The investigation follows the shutdown last year of the Sturgis
Continue Reading Abbott’s formula plant at Sturgis is the target of criminal investigation
With the infant formula shortage moving into its second year, the company most associated with it is making some significant announcements.
Abbott Nutrition let Ohio Gov. Mike DeWine announce that its new $536 million formula
Continue Reading Abbott will expand infant formula production from the Ohio site — but not until 2026.
An outbreak of infections from Salmonella Typhimurium is slowly growing according to the FDA, and an investigation into an outbreak of E. coli infections has been closed.
For the Salmonella outbreak, the number of patients has
Continue Reading Patient count growing in Salmonella outbreak from unknown source; other investigations ongoing
Both the FDA and the USDA have announced new outbreaks, but have provided virtually no details on the situations.
The U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) reports that it is investigating
Continue Reading USDA, FDA relatively mum on new outbreaks
A new outbreak of Listeria monocytogenes infections from a not yet identified food has been added to the list of outbreaks under investigation by the Food and Drug Administration.
There are two confirmed patients, but the FDA
Continue Reading FDA reports another new outbreak of infections from listeria monocytogenes
A decidedly supply-side solution is shaping up to solve the infant formula shortage that’s been plaguing the United States for the past eight months or so. Perhaps sooner, rather than later, the shortages are going
Continue Reading More capacity turning out to be the answer to the infant formula shortageA weekly update of outbreak investigations posted by the FDA shows one investigation has ended and another outbreak has one additional patient.
The Food and Drug Administration along with the Centers for Disease Control and
Continue Reading FDA reports closing ice cream investigation; continues with work on other outbreaks
The FDA is continuing to investigate several foodborne illness outbreaks and has added a new one to its list.
As of Oct. 26, there had been 10 patients confirmed in the new outbreak of infections
Continue Reading Outbreak investigations continuing; one new investigation added to FDA’s list
Abbott Nutrition’s Chairman, and Chief Executive Officer, Robert Ford has announced that his company is putting up $500 million for a new infant formula manufacturing facility at a location yet to be determined.
His announcement
Continue Reading Abbott Nutrition puts up $500 million for new state of art baby formula production